This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
REBLOZYL is a prescription medicine used to treat anemia (low red blood cells) in adults with MDS-RS or myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) who need regular red blood cell (RBC) transfusions and have not responded well to or cannot receive an erythropoiesis-stimulating agent (ESA).
REBLOZYL is not for use as a substitute for RBC transfusions in people who need immediate treatment for anemia.
It is not known if REBLOZYL is safe or effective in children. REBLOZYL may help lower the number of RBC transfusions you need.
It’s important that you learn about how REBLOZYL works before starting treatment. This can help you better understand why your doctor prescribed REBLOZYL. It can also make you feel more confident when talking with your healthcare team.
This means that there are more mature RBCs in the bloodstream.
Starting a different treatment can be a hopeful time. It might also bring some anxiety about what happens next, and there can be a lot to learn when you get started. To help with this time of change, there are resources and support to help you get the most from your treatment.